Regulators say there is no evidence that the milk poses a danger or that a live virus is present
India gives Biological E nod to study its COVID-19 vaccine in children, teens
India has granted homegrown drugmaker Biological E permission to begin midstage studies of its COVID-19 vaccine in children and adolescents, according to an official statement on Friday.
Published : 3 Sept 2021, 09:51 AM
Updated : 3 Sept 2021, 09:51 AM
The Drugs Controller General of India (DCGI) gave the approval to the Hyderabad-based pharmaceutical company on Sept 1, the statement said.
The company will study the safety and tolerability of its vaccine, CORBEVAX, in this population, it added.
So far, six vaccines have been authorized for use in the country where only about 11.28 percent of the entire population has been fully vaccinated so far, according to Johns Hopkins data.
Of these, the COVID-19 shots for adults by Bharat Biotech and Zydus Cadila have been indigenously developed.
In late August, India also approved Cadila's COVID-19 vaccine, the world's first DNA shot against the virus, for emergency use in children aged 12 years and above.
Biological E is also running a late-stage trial of its vaccine in adults.
RELATED STORIES
Doctors demand arrest of those involved in recent attacks on two physicians in the district
At least seven people have died from suspected heatstroke in the country
Bangladesh has already seen five deaths from ‘heatstroke’ at the start of the summer
